Thymalin vs Thymogen

Overview

Thymalin and Thymogen represent two generations of Russian thymic peptide research. Thymalin is an extract from calf thymus containing multiple peptides, while Thymogen (glutamyl-tryptophan) is a synthetic dipeptide developed as a defined, standardized successor. Both have been used clinically in Russia for decades but lack Western regulatory approval.

This comparison helps researchers understand the relationship between these peptides and their respective evidence bases.

Key Facts

Aspect	Thymalin	Thymogen
Also Known As	Timalin, Thymic Factor	EW dipeptide, Glu-Trp
Type	Polypeptide complex	Defined dipeptide
Structure	Multiple peptides (~10 kDa)	2 amino acids (333 Da)
Sequence	EW, KE, EDP (active components)	Glu-Trp (EW)
Origin	Calf thymus extract	Synthetic
Russian Approval	Yes (1970s)	Yes

Historical Development

Period	Thymalin	Thymogen
Development	1970s	1980s-1990s
Rationale	Thymus replacement	Standardization of thymalin
Approach	Natural extract	Synthetic active component
Clinical Use	Decades in Russia	Decades in Russia

Development Relationship

Thymogen was developed as an attempt to identify and synthesize the active component(s) of thymalin. The EW (glutamyl-tryptophan) dipeptide was identified as one of the key immunomodulatory sequences within the thymalin complex.

Mechanism Comparison

Aspect	Thymalin	Thymogen
Primary Action	T-cell differentiation	T-cell modulation
Cytokine Effects	IL-1B, IL-6, TNF-a modulation	IL-2, IFN-gamma modulation
Innate Immunity	NK cell enhancement	Neutrophil activation
Pathway	NF-kB inhibition	MAPK modulation

Thymalin Mechanisms

1. T-Cell Differentiation

   • HSC to mature T-lymphocyte conversion
   • CD44/CD117 downregulation
   • CD28 (mature T-cell marker) upregulation

2. Cytokine Modulation

   • Pro-inflammatory cytokine suppression
   • NF-kB pathway inhibition
   • Anti-inflammatory balance

3. Gene Regulation

   • Proposed DNA binding by short peptide components
   • Epigenetic effects claimed

Thymogen Mechanisms

1. T-Cell Modulation

   • T-cell differentiation activation
   • MHC complex recognition enhancement
   • Cyclic nucleotide changes

2. Cytokine Regulation

   • IL-2 and IFN-gamma modulation
   • TNF/IL-6 inhibition (via MAPK)
   • Balanced immune response

3. Innate Immunity

   • Neutrophil chemotaxis activation
   • Phagocytosis enhancement

Evidence Quality

Factor	Thymalin	Thymogen
Human Studies	8	6
Preclinical Studies	22	19
Russian Clinical Use	Decades	Decades
Western Validation	None	1 Western study (2022)
Overall Evidence	Low	Low

Thymalin Research

Finding	Type	Source
T-cell markers modulated	In vitro	Khavinson 2020
92% lymphocyte increase (COVID)	Human observational	Linkova 2021
2-fold mortality reduction (elderly)	Human observational	Khavinson 2003
Cytokine suppression	Animal	Lunin 2008

Thymogen Research

Finding	Type	Source
94.4% immunodeficiency improvement	Human observational	Morozov 1997
T-cell differentiation activation	Human observational	Khavinson 1997
TNF/IL-6 inhibition in macrophages	In vitro	Avolio 2022
Anti-tumor effects (rats)	Animal	Anisimov 2000

Clinical Applications

Russian Indications

Indication	Thymalin	Thymogen
Secondary immunodeficiency	Yes	Yes
Respiratory infections	Yes	Yes (nasal spray)
Post-infection recovery	Yes	Yes
Diabetes immune dysfunction	Studied	Studied
Age-related immune decline	Yes	Yes

Formulations (Russia)

Factor	Thymalin	Thymogen
Injectable	Yes	Yes
Intranasal	No	Yes (spray)
Oral	No	Research only

Administration

Aspect	Thymalin	Thymogen
Typical Route	Intramuscular/Subcutaneous	Subcutaneous/Intranasal
Duration	5-10 day courses	Variable

Side Effect Profiles

Thymalin

Effect	Frequency	Notes
Injection site reactions	Common	Typical for peptide
Flu-like symptoms	Occasional	Immune activation
Generally well-tolerated	Yes	Russian clinical experience

Thymogen

Effect	Frequency	Notes
Local reactions	Occasional	Injection site
Nasal irritation	Common (spray)	With intranasal use
Generally well-tolerated	Yes	Russian clinical experience

Quality and Sourcing

Thymalin Concerns

Issue	Impact
Batch variability	Composition may differ
Bovine origin	Theoretical prion concerns
Standardization	Difficult to verify
Western availability	Research chemical only

Thymogen Advantages

Factor	Benefit
Defined structure	Consistent composition
Synthetic	No animal-derived concerns
Easy to verify	Simple dipeptide
Reproducible	Standard synthesis

Regulatory Status

Aspect	Thymalin	Thymogen
Russian Approval	Yes (decades)	Yes
FDA Status	Not approved	Not approved
EMA Status	Not approved	Not approved
Western Access	Research chemical	Research chemical

Comparison for Different Needs

For Immune Support Research

Factor	Thymalin	Thymogen
Approach	Multi-peptide complex	Single defined peptide
Standardization	Poor	Good
Mechanism Complexity	Multiple pathways	Defined pathways
Research Reproducibility	Lower	Higher

For Longevity Research

Factor	Thymalin	Thymogen
Aging studies	Yes (mortality data)	Yes (lifespan studies)
Geroprotective claims	Yes	Yes
Anti-tumor effects	Not primary	Studied in animals

Cost and Practicality

Factor	Thymalin	Thymogen
Relative Cost	Higher	Lower
Synthesis Complexity	N/A (extract)	Simple dipeptide
Stability	Good (lyophilized)	Good (lyophilized)
Quality Verification	Difficult	Easier

Summary

Factor	Thymalin	Thymogen
Structure	Polypeptide complex	Dipeptide (EW)
Origin	Bovine thymus	Synthetic
Standardization	Variable	Consistent
Evidence Level	Moderate	Moderate
Russian Approval	Yes	Yes
Western Approval	No	No
Mechanism	Multiple pathways	Defined pathways

Key Takeaways

1. Related development: Thymogen was derived from thymalin research as standardized active component
2. Both Russian-approved: Decades of clinical use in Russia, but no Western regulatory approval
3. Thymogen is defined: Single dipeptide vs. complex mixture offers reproducibility advantages
4. Similar indications: Both used for immunodeficiency and immune support in Russian medicine
5. Evidence limitations: Both lack rigorous Western clinical trials
6. Thymalin concerns: Bovine origin raises theoretical safety questions
7. Western availability: Both accessible only as research chemicals
8. Quality differs: Thymogen easier to verify than complex thymalin extract

---

This comparison is for educational purposes only. Neither peptide is FDA-approved. Both are used clinically in Russia but available only as research chemicals in Western countries.